Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Psychiatry Research
|
March 7, 2012
Anxiety and negative self-schemas mediate the association between childhood maltreatment and paranoia
Helen L Fisher, Elizabeth Appiah-Kusi, Celina Grant
The International Journal of Neuropsychopharmacology
|
February 15, 2018
Human Striatal Response to Reward Anticipation Linked to Hippocampal Glutamate Levels
Matthijs G Bossong, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Bjpsych Open
|
May 12, 2022
Prevalence of mental disorders in defendants at criminal court
Penelope Brown, Ioannis Bakolis, Elizabeth Appiah-Kusi, et al.
Plos One
|
April 27, 2018
Fitness to plead: Development and validation of a standardised assessment instrument
Penelope Brown, Daniel Stahl, Elizabeth Appiah-Kusi, et al.
British Journal of Hospital Medicine (London, England : 2005)
|
October 24, 2025
Recent Innovations to Detect and Intervene to Prevent Opioid Overdose Deaths
John Strang, Elizabeth Appiah-Kusi, Edward Chesney, et al.
Psychiatry Research. Neuroimaging
|
December 3, 2025
A single dose of cannabidiol modulates the relationship between hippocampal glutamate and learning-related prefrontal activation in individuals at Clinical High Risk of Psychosis
Yiling Shi, Cathy Davies, Robin Wilson, et al.
Suicide & Life-Threatening Behavior
|
February 15, 2020
Imaginator: A Proof-of-Concept Feasibility Trial of a Brief Imagery-Based Psychological Intervention for Young People Who Self-Harm
Martina Di Simplicio, Elizabeth Appiah-Kusi, Paul Wilkinson, et al.
Translational Psychiatry
|
August 24, 2019
Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
Robin Wilson, Matthijs G Bossong, Elizabeth Appiah-Kusi, et al.
JAMA Psychiatry
|
September 1, 2018
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial
Sagnik Bhattacharyya, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Translational Psychiatry
|
September 14, 2020
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
Cathy Davies, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Psychiatry Research
|
March 7, 2012
Anxiety and negative self-schemas mediate the association between childhood maltreatment and paranoia
Helen L Fisher, Elizabeth Appiah-Kusi, Celina Grant
The International Journal of Neuropsychopharmacology
|
February 15, 2018
Human Striatal Response to Reward Anticipation Linked to Hippocampal Glutamate Levels
Matthijs G Bossong, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Bjpsych Open
|
May 12, 2022
Prevalence of mental disorders in defendants at criminal court
Penelope Brown, Ioannis Bakolis, Elizabeth Appiah-Kusi, et al.
Plos One
|
April 27, 2018
Fitness to plead: Development and validation of a standardised assessment instrument
Penelope Brown, Daniel Stahl, Elizabeth Appiah-Kusi, et al.
British Journal of Hospital Medicine (London, England : 2005)
|
October 24, 2025
Recent Innovations to Detect and Intervene to Prevent Opioid Overdose Deaths
John Strang, Elizabeth Appiah-Kusi, Edward Chesney, et al.
Psychiatry Research. Neuroimaging
|
December 3, 2025
A single dose of cannabidiol modulates the relationship between hippocampal glutamate and learning-related prefrontal activation in individuals at Clinical High Risk of Psychosis
Yiling Shi, Cathy Davies, Robin Wilson, et al.
Suicide & Life-Threatening Behavior
|
February 15, 2020
Imaginator: A Proof-of-Concept Feasibility Trial of a Brief Imagery-Based Psychological Intervention for Young People Who Self-Harm
Martina Di Simplicio, Elizabeth Appiah-Kusi, Paul Wilkinson, et al.
Translational Psychiatry
|
August 24, 2019
Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
Robin Wilson, Matthijs G Bossong, Elizabeth Appiah-Kusi, et al.
JAMA Psychiatry
|
September 1, 2018
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial
Sagnik Bhattacharyya, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Translational Psychiatry
|
September 14, 2020
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
Cathy Davies, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Page
of 2